Dietary sodium and inhibition of neutral endopeptidase 24.11 in essential hypertension.
Donald R.J. Singer(Charing Cross Hospital), Graham A. MacGregor(Queen Mary University of London), Michelle A. Miller(University of Warwick), Nirmala D. Markandu(University of London), Giuseppe A. Sagnella(Charing Cross Hospital), M. G. Buckley(St George's Hospital)
Cited by 42
Related Papers
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
|The Lancet Diabetes & Endocrinology|2018|340